Carcinoid Tumors
April 2017 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Carcinoid Tumors abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Carcinoid Tumors. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Carcinoid Tumors. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Carcinoid Tumors every 3 months. Thank you for your ongoing subscription to this publication.

Sincerely,
Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Telotristat ethyl: a new option for the management of carcinoid syndrome.
Authors:Lamarca A, Barriuso J, McNamara MG, Hubner RA, Valle JW
Institution:a Department of Medical Oncology , The Christie NHS Foundation Trust , Manchester , UK. , UK. Manchester , UK. , UK. , UK. , UK.
Journal:Expert Opin Pharmacother. 2016 Dec;17(18):2487-2498. Epub 2016 Nov 16.

2:Atypical Carcinoid Tumor with Anaplastic Lymphoma Kinase (ALK) Rearrangement Successfully Treated by an ALK Inhibitor.
Authors:Nakajima M, Uchiyama N, Shigemasa R, Matsumura T, Matsuoka R, Nomura A
Institution:Department of Respiratory Medicine, Ibaraki Seinan Medical Center Hospital, Japan.
Journal:Intern Med. 2016;55(21):3151-3153. Epub 2016 Nov 1.

3:Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung.
Authors:Yang Z, Wang Z, Duan Y, Xu S
Institution:Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University, Beijing, China. University, Beijing, China. University, Beijing, China. University, Beijing, China. xushaofa@yeah.net.
Journal:Thorac Cancer. 2016 Nov;7(6):633-638. doi: 10.1111/1759-7714.12377. Epub 2016 Sep 6.

4:Application value of endoscopic submucosal dissection and endoscopic mucosal resection for treatment of rectal carcinoids.
Authors:Li X, Gui Y, Han W, Jiang H, Qi D, Yang Y
Institution:Department of Medical (Endoscopy), Xinxiang Central Hospital of Henan Province, Xinxiang 453000, PR China. 453000, PR China. Xinxiang 453000, PR China. Xinxiang 453000, PR China. Xinxiang 453000, PR China. Xinxiang 453000, PR China.
Journal:J Cancer Res Ther. 2016 Oct;12(Supplement):43-46. doi: 10.4103/0973-1482.191628.

5:Primary pure carcinoid tumour of the testis: A case report and review of the literature.
Authors:Takada H, Iwatsuki S, Itoh Y, Sato S, Hayase M, Yasui T
Institution:Department of Nephro-urology, Nagoya City West Medical Center. htakada@cronos.ocn.ne.jp.
Journal:Arch Ital Urol Androl. 2016 Oct 5;88(3):245-246. doi: 10.4081/aiua.2016.3.245.

6:Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors.
Authors:Wolin EM, Manon A, Chassaing C, Lewis A, Bertocchi L, Richard J, Phan AT
Institution:Medical Oncology, Montifiore Einstein Center for Cancer Care, 1695 Eastchester Rd., Second Floor, Bronx, NY, 10461, USA. ewolin@montefiore.org. Canada, 91140, Les Ulis, France. France. France. France. France.
Journal:J Gastrointest Cancer. 2016 Dec;47(4):366-374.

7:Clinicopathological study of ovarian carcinoid tumours.
Authors:McGrath S, Nicklin J
Institution:Department of Obstetrics and Gynaecology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. s.mcgrath@uq.edu.au. s.mcgrath@uq.edu.au.
Journal:Aust N Z J Obstet Gynaecol. 2016 Oct;56(5):508-513. doi: 10.1111/ajo.12503. Epub 2016 Jul 13.

8:Management of bronchial carcinoids: international practice survey among the European Society of Thoracic Surgeons.
Authors:Filosso PL, Guerrera F, Thomas P, Brunelli A, Lim E, Garcia-Yuste M, Asamura H, Papagiannopoulos K, Sarkaria I, Venuta F
Institution:Department of Thoracic Surgery, San Giovanni Battista Hospital, University of Torino, Italy. Torino, Italy. Mediterranean, & University Hospital System of Marseille, Marseille, France. USA. Policlinico Umberto I, Rome, Italy.
Journal:Future Oncol. 2016 Sep;12(17):1985-99. doi: 10.2217/fon-2016-0092. Epub 2016 Jun 15.

9:Pre-surgical bronchoscopic treatment for typical endobronchial carcinoids.
Authors:Guarino C, Mazzarella G, De Rosa N, Cesaro C, La Cerra G, Grella E, Perrotta F, Curcio C, Guerra G, Bianco A
Institution:A.O. dei Colli, Hosp. Monaldi, Bronchology Unit, Naples, Italy. Electronic address: carguarino@alice.it. Naples/Hosp. Monaldi, Naples, Italy. Electronic address: gennaro.mazzarella@unina2.it. nicla.derosa@libero.it. address: c_cesaro@libero.it. address: lacerragiuseppe@alice.it. Naples/Hosp. Monaldi, Naples, Italy. Electronic address: grella@hotmail.com. Naples/Hosp. Monaldi, Naples, Italy. Electronic address: perrotta572@msn.com. address: carlo.curcio.33@alice.it. Molise, Campobasso, Italy. Electronic address: germano.guerra@unimol.it. Molise, Campobasso, Italy. Electronic address: andrea.bianco@unimol.it.
Journal:Int J Surg. 2016 Sep;33 Suppl 1:S30-5. doi: 10.1016/j.ijsu.2016.05.054. Epub 2016 May 30.

For a FREE PREVIEW of the Medifocus Guidebook on Carcinoid Tumors click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Carcinoid Tumors click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Carcinoid Tumors...
at a Special 20% Discount


Medifocus Guidebook on Carcinoid Tumors

Updated: January 30, 2017
144 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Carcinoid Tumors is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

CT62405794

Coupon Expires: May 26, 2017



What Our Customers Are Saying...

"The MediFocus Guidebook on Carcinoid Tumors helped me prepare for my operation. It was reassuring to be able to communicate with my surgeon and the consulting doctors having knowledge about my condition."
P.T.
Newcastle, England


"The Guide is detailed and written in a way that the layman can readily understand. My wife, who has just had a Carcinoid Tumor removed, is reading it as I write this. It will be helpful in her recovery and ongoing therapy."
F.B.
Nanaimo, British Columbia


"The MediFocus Guidebook on Carcinoid Tumors was extremely informative and easy to understand. Now I'm able to discuss my condition with my doctor in an informed manner and make better decisions regarding my treatment."
J.P.F.
Agoura Hills, California



  
Medifocus Digest Alert is published monthly by Medifocus, Inc.
6810 Park Heights Avenue, Suite C5, Baltimore, MD 21215 USA
Copyright © 2013 Medifocus, Inc. All rights reserved.